Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.366ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.366ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.380EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.380EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.380ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.380ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.380EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.380EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.380ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.380ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.148EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.148EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.148ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.148ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.148EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.148EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.148ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.148ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.382EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.382ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.382ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.382EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.382EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.382ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.382ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.356EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.356ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.356ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.356EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.356EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.356ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.356ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.376EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.376EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.376ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.376ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.376EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.376EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.376ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.376ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAMEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAMECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XAMECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAMEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAMEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used